Mouse models of autoimmune uveitis
- PMID: 25777760
- DOI: 10.2174/1381612821666150316122928
Mouse models of autoimmune uveitis
Abstract
Uveitis is a sight threatening intraocular inflammation accounting for approximately 10% of blindness worldwide. On the basis of aetiology, disease can be classified as infectious or non-infectious; and by anatomical localization of inflammation as anterior, posterior and panuveitis. Non-infectious uveitis is believed to be autoimmune in nature with Th1 and Th17 cells being identified as the prominent effector cell types. Numerous animal models of autoimmune uveitis were developed contributing to our understanding of this inflammatory condition. The classical peptide-induced experimental autoimmune uveoretinitis (EAU) model resembles human posterior uveitis due to the recurrent/relapsing nature of the disease; while the intraocular inflammation triggered by administration of bacterial lipopolisaccharide (endotoxin-induced uveitis, EIU) mimics closely anterior uveitis. The clinical need for novel, more targeted forms of anti-inflammatory therapy has emerged as currently available therapeutic strategies are associated with a number of adverse effects and intolerance in patients. This review summarises knowledge about existing mouse models of uveitis, discusses mechanisms driving intraocular inflammation and describes possible customised translational treatment strategies that can be potentially used in the clinic to prevent blindness in patients.
Similar articles
-
Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354.Biochem Biophys Res Commun. 2020 May 7;525(3):589-594. doi: 10.1016/j.bbrc.2020.02.117. Epub 2020 Feb 27. Biochem Biophys Res Commun. 2020. PMID: 32115150
-
Kurarinone regulates Th17/Treg balance and ameliorates autoimmune uveitis via Rac1 inhibition.J Adv Res. 2025 Mar;69:381-398. doi: 10.1016/j.jare.2024.03.013. Epub 2024 Mar 24. J Adv Res. 2025. PMID: 38522752 Free PMC article.
-
A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis.Curr Mol Med. 2017;17(3):211-220. doi: 10.2174/1566524017666170807144009. Curr Mol Med. 2017. PMID: 28782485 Free PMC article.
-
Cytokines in autoimmune uveitis.J Interferon Cytokine Res. 2011 Oct;31(10):733-44. doi: 10.1089/jir.2011.0042. Epub 2011 Jul 25. J Interferon Cytokine Res. 2011. PMID: 21787221 Free PMC article. Review.
-
[Translational research with experimental autoimmune uveoretinitis (EAU)].Nippon Ganka Gakkai Zasshi. 2007 Mar;111(3):137-58; discussion 159. Nippon Ganka Gakkai Zasshi. 2007. PMID: 17402560 Review. Japanese.
Cited by
-
Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space.AAPS J. 2017 Nov;19(6):1656-1668. doi: 10.1208/s12248-017-0128-y. Epub 2017 Aug 9. AAPS J. 2017. PMID: 28795351 Review.
-
Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis.Pharmaceutics. 2024 May 27;16(6):723. doi: 10.3390/pharmaceutics16060723. Pharmaceutics. 2024. PMID: 38931845 Free PMC article.
-
3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular Inflammation.Int J Mol Sci. 2022 Nov 17;23(22):14196. doi: 10.3390/ijms232214196. Int J Mol Sci. 2022. PMID: 36430674 Free PMC article.
-
Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope-Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice.Invest Ophthalmol Vis Sci. 2025 Jan 2;66(1):13. doi: 10.1167/iovs.66.1.13. Invest Ophthalmol Vis Sci. 2025. PMID: 39775697 Free PMC article.
-
Colitis in a transgenic mouse model of autoimmune uveitis may be induced by neoantigen presentation in the bowel.Sci Rep. 2023 Jan 23;13(1):1256. doi: 10.1038/s41598-022-27018-9. Sci Rep. 2023. PMID: 36690619 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical